Microbot Medical Shares Surge Following Key FDA Clearance
Published on 09/24/2025 at 11:54 | Redaktion boerse-global.de
Microbot Medical’s stock continues its remarkable upward trajectory, posting a 5.14% gain yesterday to close at $3.48. This marks the third consecutive day of positive momentum for the equity. The longer-term performance is even more striking, with the share price having skyrocketed 235% over the past month and an impressive 300% across the last twelve months.
The recent momentum was further bolstered by a significant financial development on September 15. The company secured access to up to $92.2 million through the exercise of outstanding preferred stock options. An initial tranche of $25.2 million has already been realized, with an additional $4 million expected by mid-October. Management intends to deploy this capital to accelerate the commercial launch of its LIBERTY® system, potentially fund acquisitions, and expand intellectual property rights.... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
